Published in Science · View the paper (DOI)
Researchers at Penn State and Stanford University discovered that blocking IDO1 enzyme can rescue memory and brain function in models of Alzheimer's disease. This breakthrough suggests that IDO1 inhibitors, already developed for cancer treatment, could be used to treat early stages of neurodegenerative diseases.
Coverage from 2 institutions